Close Menu

Cleveland Clinic

NEW YORK (GenomeWeb News) – Cleveland Clinic today said that it will recruit Parkinson's disease patients for 23andMe and the consumer genetics firm's ongoing research efforts in that area.

NAME: John Hackett, Jr.
POSITION: Volwiler research fellow and manager, emerging pathogens and virus discovery, Abbott Diagnostics

A Cleveland Clinic official recently discussed three investigations that have added to the body of knowledge about how genomic medicine should be adopted into the existing healthcare infrastructure.

The company said it has identified nearly 300 genes linked to prostate cancer recurrence in men who have had a previous radical prostatectomy.

The four researchers are among 17 new hires planned for the Taussig Cancer Institute over the next three years, following the planned renovation of the institute's original 3,600 square feet of lab space, completed in 1928 and last refurbished in the 1950s.

In the first deal, the clinic has taken an undisclosed equity stake in FTA to co-develop antimicrobial products for FTA's development partner Pure Bioscience. Meantime, a collaboration with Aspect Medical Systems will analyze the clinic's electronic medical record system to improve post-operative outcomes.

The Center for Stem Cell and Regenerative Medicine, which comprises researchers from Ohio academic institutions, research hospitals, and the private sector, will use the grant to fund nine new research projects this year and at least eight in coming years.

Taking vitamin E, selenium, or both for several weeks before having a prostatectomy can alter gene expression in prostate cancer biopsy samples.


Nebula Genomics will be auctioning George Church's genome as a nonfungible token, according to The Scientist.

Anthony Gregg, the outgoing president of the American College of Medical Genetics and Genomics, has resigned after using racially insensitive language. 

Facebook has developed an artificial intelligence approach to predict how drugs interact in cells, New Scientist reports.

In PNAS this week: adaptations among high-altitude Mycobacterium tuberculosis, response of multiple myeloma cells to chemotherapy-induced stress, and more.